What You Should Know:
- A new report by Accenture, "Reinventing R&D in the Age of AI," paints a clear picture: the biopharmaceutical industry stands at a critical juncture. Companies that embrace intelligent technologies like AI and machine learning are poised to become the future's leaders, while those clinging to outdated methods risk falling behind.
- Accenture's report serves as a roadmap, offering valuable insights and practical steps for companies ready to embrace the
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
M&A: Alcon Acquires BELKIN Vision for $81M
What You Should Know:
- Alcon (SIX/NYSE: ALC), a company in eye care, announced today the completion of its acquisition of BELKIN Vision for a total of $81M. This strategic move strengthens Alcon's position in the glaucoma treatment landscape.
- By acquiring BELKIN Vision's DSLT technology, Alcon expands its treatment options for glaucoma patients. This minimally invasive procedure offers a new tool for physicians, with the potential to improve patient care and outcomes. With planned
Read More
How Healthcare Automation Is Enhancing a Patient’s Diagnostic Testing Experience
With the influx of technology, the healthcare industry has experienced tremendous change over the years. More and more healthcare facilities are investing in innovative tools that can help automate and significantly improve a patient’s diagnostic testing experience. In this article, let’s explore the myriad benefits of healthcare automation and how it has revolutionized the diagnostic testing process and made it a positive patient experience.
Efficient Scheduling
With the
Read More
UltraSight Joins Butterfly Garden to Expand AI Real-Time Guidance Across POC Ultrasound Devices
What You Should Know:
- UltraSight, a leader in AI-powered cardiac imaging, announced it has joined Butterfly Garden, an artificial intelligence (AI) Marketplace launched by Butterfly Network, a pioneer in portable ultrasound technology to improve access to cardiac care.
- The collaboration empowers medical professionals and paves the way for a future of faster and more efficient cardiac diagnostics.
Combatting Cardiovascular Disease with AI
Cardiovascular disease (CVD)
Read More
Amwell Announces Reverse Stock Split to Maintain NYSE Listing
What You Should Know:
- Amwell (NYSE: AMWL), a leading provider of telehealth software, announced today a one-for-twenty (1-for-20) reverse stock split for all classes of its common stock.
- The stock split move aims to regain compliance with the New York Stock Exchange's (NYSE) minimum share price requirement of $1.00.
Effective Date and Share Adjustments
The reverse stock split will become effective on July 10, 2024, at 5:00 p.m. EDT. Following the split, the number of
Read More
Walmart Exits Virtual Health Market with Sale of MeMD to Fabric
What You Should Know:
- Fabric, a healthcare technology company focused on care enablement, announced today the acquisition of MeMD from Walmart Inc. (NYSE: WMT). MeMD is a recognized leader in virtual healthcare, offering behavioral, urgent, and primary care services to millions of individuals.
- This strategic acquisition positions Fabric to be a major player in the virtual healthcare landscape. By combining Fabric's care enablement platform with MeMD's established virtual care
Read More
Noom Unveils AI-Powered Food Logging and Welli Assistant to Supercharge Health Coaching
What You Should Know:
- Noom, the leader in digital health coaching for chronic disease prevention, is revolutionizing its platform with the launch of two cutting-edge AI features: AI food logging and Welli, their new AI personal health assistant.
- The launch of AI food logging and Welli reinforces Noom's commitment to leveraging technology for sustainable behavior change. These features simplify meal tracking, provide instant support, and free up coaches to deliver personalized
Read More
23andMe and Nightingale Health Partner to Offer Blood-Based Risk Assessment Pilot
What You Should Know:
- 23andMe Holding Co., a leading player in preventative health and therapeutics, and Nightingale Health, a pioneer in biomarker testing, announced a collaboration to pilot Nightingale's blood metabolomics panel with a group of 23andMe members.
- This pilot program represents a significant step forward in personalized health assessment. By combining genetic and blood biomarker data, 23andMe and Nightingale Health are paving the way for a future where individuals
Read More
Adventist Health Selects The Garage’s Bridge Platform to Advance Value-Based Care Initiatives
What You Should Know:
- The Garage, a leading population health management technology company, announced a strategic partnership with Adventist Health, a prominent non-profit integrated health system. Adventist Health will leverage The Garage's Bridge platform to further its value-based care initiatives across its diverse patient population.
- The Garage, headquartered in Orlando, Florida, is a population health management leader dedicated to improving healthcare delivery. By
Read More
ONWARD Medical Secures $56.6M Loan to Advance Spinal Cord Stimulation Therapies
What You Should Know:
- ONWARD Medical N.V. (Euronext: ONWD), a leading medical technology company specializing in innovative spinal cord stimulation therapies, announced the signing of a loan agreement of up to €52.5M ($56.6M) with Runway Growth Capital LLC, a U.S.-based lender.
- This strategic partnership will provide vital funding for the company's continued growth and advancement of life-changing SCS therapies for people with spinal cord injury (SCI).
- ONWARD Medical is a
Read More
